Oral News and Research

RSS

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche announced today that results from a randomized Phase III clinical study of the investigational drug Tarceva (erlotinib HCl), in combination with gemcitabine chemotherapy met its primary endpoint of improving survival.

20 Sep 2004

New oral gel used instead of injection to deliver drugs

Scientists in India have developed a new gel that is taken orally and is capable of delivering drugs to manage diseases often requiring an injection.

20 Sep 2004

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

The Chairman of the U.S. Senate Special Committee on Aging is encouraging those on Medicare who have cancer and other serious diseases to consider signing up for a new demonstration prescription drug assistance program.

18 Sep 2004

A misconception that eating wasabi decongests the nose

Wasabi, (Wasabia japonica) is commonly known as the Japanese horseradish used to enhance the enjoyment of sushi.

18 Sep 2004

Oral appliances effective in treating obstructive sleep apnea

Obstructive sleep apnea syndrome (OSAS) is a disorder characterized by repeated episodes of reductions or cessation in breathing during sleep. Millions of Americans, both men and women, have this medical problem

18 Sep 2004

Adenotonsillectomy resolves child sleep disorders

Within the last ten years, the primary reason that children have had surgery to remove their tonsils and adenoids is not infection but obstructive sleep apnea.

18 Sep 2004

Study hints at antioxidants being able to prevent and restore hearing loss

In a preliminary study, researchers find that vitamin E may be effective in restoring sudden onset hearing loss of unknown origin (idiopathic sudden hearing loss). These findings suggest that further research may reveal the role of antioxidants in the prevention and restoration of hearing loss.

18 Sep 2004

Children with complications from acute sinusits may experience significant illness from their infection

Acute sinusitis is a common pediatric disorder, accounting for 21 percent of children’s antibiotic prescriptions.

17 Sep 2004

Study compares coblation tonsillectomy to traditional method of removing tonsils

Tonsillectomy remains one of the most common childhood surgeries with an increasing number of the surgeries being done to treat obstructive sleep apnea or sleep disordered breathing.

17 Sep 2004

Genetically modified bacterium as remedy for intestinal diseases

Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) at Ghent University are joining the fight against chronic intestinal disease with a genetically modified bacterium (Lactococcus lactis).

14 Sep 2004

Study tests inflammatory response of Down Syndrome patients

Almost all people with Down syndrome have periodontal disease, and a Medical College of Georgia dentist suspects that an abnormal inflammatory response is the culprit.

13 Sep 2004

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Potential new drug for the treatment of sickle cell disease

The results were published in the June 2004 issue of The British Journal of Haematology (BJH). MX-1520 is a prodrug of vanillin, a very popular food additive generally regarded as safe (GRAS) by the FDA.

13 Sep 2004

Treatment with vitamin A and an omega-3 fatty acid slows down the progression of retinitis pigmentosa

Patients with retinitis pigmentosa, a progressive eye disease that can cause vision loss, who were treated with vitamin A and docosahexaenoic acid (DHA), a kind of omega-3 fatty acid, did not experience slowing of the progression of their disease

12 Sep 2004

Herbals, surgery and anesthesia don't always mix

The woman who swears by gingko biloba wonders why her mouth won't stop bleeding after wisdom tooth surgery. What she doesn't know is that the herbal remedy she takes religiously to enhance mental alertness also acts as a powerful blood thinner that inhibits clotting.

10 Sep 2004